Cargando…
Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian cancer cell viability and migration and tumor growth
Ovarian cancer is the most lethal gynecological cancer type in the United States. The success of current chemotherapies is limited by chemoresistance and side effects. Targeted therapy is a promising future direction for cancer therapy. In the present study, the efficacy of co-targeting IL-6 and IL-...
Autores principales: | Zhang, Ruijie, Roque, Dana M., Reader, Jocelyn, Lin, Jiayuh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973967/ https://www.ncbi.nlm.nih.gov/pubmed/35315502 http://dx.doi.org/10.3892/ijo.2022.5340 |
Ejemplares similares
-
A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin
por: Zhang, Ruijie, et al.
Publicado: (2021) -
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
por: Wang, Yina, et al.
Publicado: (2017) -
Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
por: Lane, Denis, et al.
Publicado: (2011) -
Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
por: Jayatilaka, Hasini, et al.
Publicado: (2017) -
Exosomal-miR-10a derived from colorectal cancer cells suppresses migration of human lung fibroblasts, and expression of IL-6, IL-8 and IL-1β
por: Wang, Jian, et al.
Publicado: (2021)